Strategic Advocates’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$131K Sell
433
-5,816
-93% -$1.95M 0.58% 39
2025
Q4
$2.33M Buy
6,249
+873
+16% +$312K 0.6% 28
2025
Q3
$1.79M Buy
5,376
+1,014
+23% +$323K 0.47% 37
2025
Q2
$1.39M Buy
4,362
+1,342
+44% +$378K 0.41% 39
2025
Q1
$813K Buy
3,020
+1,213
+67% +$359K 0.28% 58
2024
Q4
$536K Sell
1,807
-572
-24% -$164K 0.18% 62
2024
Q3
$645K Sell
2,379
-920
-28% -$229K 0.23% 64
2024
Q2
$764K Sell
3,299
-2,201
-40% -$510K 0.3% 49
2024
Q1
$1.25M Sell
5,500
-1,389
-20% -$288K 0.48% 40
2023
Q4
$1.29M Buy
6,889
+181
+3% +$29.1K 0.55% 41
2023
Q3
$1M Buy
+6,708
New +$1.1M 0.47% 46

Other funds holding AXP

Strategic Advocates's AXP Position: Q1 2026 in Review

Strategic Advocates reduced its American Express (AXP) stake by 93% in Q1 2026, selling an estimated $1.95M and leaving 433 shares worth $131K. The position accounts for 0.58% of the portfolio, ranked #39.

Strategic Advocates first reported a position in AXP in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.33M in Q4 2025. 2,888 funds tracked by Wall St. Rank hold AXP as of Q1 2026.

  • Strategic Advocates held 433 shares of American Express worth $131K as of Q1 2026.
  • Strategic Advocates sold 5,816 American Express shares in Q1 2026, an estimated $1.95M.
  • American Express made up 0.58% of Strategic Advocates's portfolio in Q1 2026, its #39 holding.
  • Strategic Advocates first reported a position in American Express in Q3 2023 and has held it in 11 quarters since.
  • Strategic Advocates's American Express position peaked at $2.33M in Q4 2025.
  • 2,888 funds tracked by Wall St. Rank held American Express as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.